John Whelchel

764 total citations
9 papers, 477 citations indexed

About

John Whelchel is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, John Whelchel has authored 9 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Transplantation, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Psychiatry and Mental health. Recurrent topics in John Whelchel's work include Renal Transplantation Outcomes and Treatments (7 papers), Neurological Complications and Syndromes (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). John Whelchel is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Neurological Complications and Syndromes (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). John Whelchel collaborates with scholars based in United States, Switzerland and Italy. John Whelchel's co-authors include John C. Magee, Paolo Rigotti, V. Cambi, John P. Leone, Julio Pascual, Josette Eris, Ronaldo Esmeraldo, Scott B. Campbell, B. Bourbigot and Š Vı́tko and has published in prestigious journals such as American Journal of Kidney Diseases, Transplantation and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

John Whelchel

9 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Whelchel United States	9	398	270	103	70	60	9	477
Ronaldo Esmeraldo Brazil	8	326 0.8×	222 0.8×	89 0.9×	59 0.8×	101 1.7×	17	447
S. Girardot-Seguin France	6	399 1.0×	215 0.8×	141 1.4×	59 0.8×	94 1.6×	7	452
Wilson Aguiar Brazil	12	280 0.7×	148 0.5×	146 1.4×	57 0.8×	82 1.4×	31	461
M Cantarovich Canada	10	331 0.8×	239 0.9×	50 0.5×	50 0.7×	36 0.6×	27	445
M. Cabello Spain	11	223 0.6×	135 0.5×	58 0.6×	96 1.4×	83 1.4×	35	383
David Schladt United States	9	380 1.0×	138 0.5×	75 0.7×	59 0.8×	37 0.6×	15	458
A. Humar United States	7	263 0.7×	255 0.9×	55 0.5×	29 0.4×	98 1.6×	11	389
M.W. Büchler Germany	8	247 0.6×	213 0.8×	35 0.3×	42 0.6×	97 1.6×	15	412
W. Guan United States	6	352 0.9×	96 0.4×	67 0.7×	57 0.8×	33 0.6×	8	420
Elizabeth E. Ashcraft United States	11	198 0.5×	201 0.7×	28 0.3×	39 0.6×	108 1.8×	15	345

Countries citing papers authored by John Whelchel

Since Specialization

Citations

This map shows the geographic impact of John Whelchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Whelchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Whelchel more than expected).

Fields of papers citing papers by John Whelchel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Whelchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Whelchel. The network helps show where John Whelchel may publish in the future.

Co-authorship network of co-authors of John Whelchel

This figure shows the co-authorship network connecting the top 25 collaborators of John Whelchel. A scholar is included among the top collaborators of John Whelchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Whelchel. John Whelchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Pescovitz, Mark D., Flavio Vincenti, Marquis Hart, et al.. (2007). Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients. British Journal of Clinical Pharmacology. 64(6). 758–771. 20 indexed citations

Cibrik, Diane M., Herwig‐Ulf Meier‐Kriesche, Barbara A. Bresnahan, et al.. (2007). Renal function with cyclosporine C₂monitoring, enteric‐coated mycophenolate sodium and basiliximab: a 12‐month randomized trial in renal transplant recipients. Clinical Transplantation. 21(2). 192–201. 14 indexed citations

Tedesco‐Silva, Hélio, Š Vı́tko, Julio Pascual, et al.. (2006). 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. Transplant International. 20(1). 27–36. 88 indexed citations

Lorber, Marc I., Claudio Ponticelli, John Whelchel, et al.. (2005). Therapeutic drug monitoring for everolimus in kidney transplantation using 12‐month exposure, efficacy, and safety data. Clinical Transplantation. 19(2). 145–152. 62 indexed citations

Vı́tko, Š, Hélio Tedesco‐Silva, Josette Eris, et al.. (2004). Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies. American Journal of Transplantation. 4(4). 626–635. 207 indexed citations

Trachiotis, Gregory D., et al.. (2003). Ten-year follow-up in patients with combined heart and kidney transplantation. Journal of Thoracic and Cardiovascular Surgery. 126(6). 2065–2071. 34 indexed citations

Kohaut, Edward C., John Whelchel, F. Bryson Waldo, & Arnold G. Diethelm. (1987). Aggressive therapy of infants with renal failure. Pediatric Nephrology. 1(2). 150–153. 25 indexed citations

Kohaut, Edward C., John Whelchel, F. Bryson Waldo, & Arnold G. Diethelm. (1985). LIVING-RELATED DONOR RENAL TRANSPLANTATION IN CHILDREN PRESENTING WITH END-STAGE RENAL DISEASE IN THE FIRST MONTH OF LIFE. Transplantation. 40(6). 725–726. 8 indexed citations

Whelchel, John, et al.. (1982). Occult Dental Infection Causing Fever in Renal Transplant Patients. American Journal of Kidney Diseases. 2(3). 354–356. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact